Genetic Disorder News and Research

RSS
Center for Excellence in Sickle Cell Disease established by Vanderbilt and Meharry

Center for Excellence in Sickle Cell Disease established by Vanderbilt and Meharry

Circadian partners with Cincinnati Children's Hospital to develop blood test diagnostic for LAM, a serious lung disease

Circadian partners with Cincinnati Children's Hospital to develop blood test diagnostic for LAM, a serious lung disease

Legislation to help speed research for cystic fibrosis and other rare diseases

Legislation to help speed research for cystic fibrosis and other rare diseases

Past exposure to pathogens leads to disease resistance spreading through populations

Past exposure to pathogens leads to disease resistance spreading through populations

Scientists identify genetic variants that increase asthma susceptibility

Scientists identify genetic variants that increase asthma susceptibility

Santaris Pharma paves way to conduct clinical trial of miravirsen in patients with HVC

Santaris Pharma paves way to conduct clinical trial of miravirsen in patients with HVC

Researchers identify new target for cystic fibrosis

Researchers identify new target for cystic fibrosis

FDA grants AGTC $1M for Phase II human clinical trial in alpha-1 antitrypsin deficiency

FDA grants AGTC $1M for Phase II human clinical trial in alpha-1 antitrypsin deficiency

IVF on the rise in Australia: Report

IVF on the rise in Australia: Report

Recommendations for developing novel therapies for hypertrophic cardiomyopathy

Recommendations for developing novel therapies for hypertrophic cardiomyopathy

bluebird bio publishes LentiGlobin gene therapy clinical trial data results

bluebird bio publishes LentiGlobin gene therapy clinical trial data results

Researchers recommend mechanism to identify hypertrophic cardiomyopathy

Researchers recommend mechanism to identify hypertrophic cardiomyopathy

Study finds new therapeutic target for polycystic kidney disease

Study finds new therapeutic target for polycystic kidney disease

Santarus expands development pipeline, adds two novel biologic drug candidates

Santarus expands development pipeline, adds two novel biologic drug candidates

Good Start Genetics to develop pre-pregnancy genetic test with completed $18M Series A financing

Good Start Genetics to develop pre-pregnancy genetic test with completed $18M Series A financing

Good Start Genetics $18 million Series A financing round co-led by Safeguard Scientifics

Good Start Genetics $18 million Series A financing round co-led by Safeguard Scientifics

Shire announces expansion of Human Genetic Therapies pipeline

Shire announces expansion of Human Genetic Therapies pipeline

Kennedy Krieger Institute receives grant for Alzheimer's disease research in Down syndrome patients

Kennedy Krieger Institute receives grant for Alzheimer's disease research in Down syndrome patients

Edimer Pharmaceuticals, CMC Biologics execute manufacturing contract to develop EDI200 recombinant protein

Edimer Pharmaceuticals, CMC Biologics execute manufacturing contract to develop EDI200 recombinant protein

Acceleron Pharma and Shire announce joint development of ACE-031 for DMD

Acceleron Pharma and Shire announce joint development of ACE-031 for DMD

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.